205 related articles for article (PubMed ID: 23516635)
1. Comparison of human hepatoma HepaRG cells with human and rat hepatocytes in uptake transport assays in order to predict a risk of drug induced hepatotoxicity.
Szabo M; Veres Z; Baranyai Z; Jakab F; Jemnitz K
PLoS One; 2013; 8(3):e59432. PubMed ID: 23516635
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibitory effect of cyclosporin A and bosentan on taurocholate uptake in human and rat hepatocytes as a function of culturing time.
Jemnitz K; Veres Z; Szabo M; Baranyai Z; Jakab F; Vereczkey L
Toxicol In Vitro; 2012 Feb; 26(1):174-81. PubMed ID: 22119333
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of canalicular and sinusoidal taurocholate efflux by cholestatic drugs in human hepatoma HepaRG cells.
Le Vée M; Moreau A; Jouan E; Denizot C; Parmentier Y; Fardel O
Biopharm Drug Dispos; 2022 Dec; 43(6):265-271. PubMed ID: 36195987
[TBL] [Abstract][Full Text] [Related]
4. Use of sandwich-cultured hepatocytes to evaluate impaired bile acid transport as a mechanism of drug-induced hepatotoxicity.
Marion TL; Leslie EM; Brouwer KL
Mol Pharm; 2007; 4(6):911-8. PubMed ID: 17963355
[TBL] [Abstract][Full Text] [Related]
5. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
Noé J; Portmann R; Brun ME; Funk C
Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
[TBL] [Abstract][Full Text] [Related]
6. Xenobiotics inhibit hepatic uptake and biliary excretion of taurocholate in rat hepatocytes.
Kemp DC; Zamek-Gliszczynski MJ; Brouwer KL
Toxicol Sci; 2005 Feb; 83(2):207-14. PubMed ID: 15509663
[TBL] [Abstract][Full Text] [Related]
7. An in vitro assay to assess transporter-based cholestatic hepatotoxicity using sandwich-cultured rat hepatocytes.
Ansede JH; Smith WR; Perry CH; St Claire RL; Brouwer KR
Drug Metab Dispos; 2010 Feb; 38(2):276-80. PubMed ID: 19910518
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a Drug-Induced, Bile Acid-Dependent Hepatotoxicity Model Using HepaRG Cells.
Susukida T; Sekine S; Nozaki M; Tokizono M; Oizumi K; Horie T; Ito K
J Pharm Sci; 2016 Apr; 105(4):1550-60. PubMed ID: 26952880
[TBL] [Abstract][Full Text] [Related]
9. Species differences in hepatobiliary disposition of taurocholic acid in human and rat sandwich-cultured hepatocytes: implications for drug-induced liver injury.
Yang K; Pfeifer ND; Köck K; Brouwer KL
J Pharmacol Exp Ther; 2015 May; 353(2):415-23. PubMed ID: 25711339
[TBL] [Abstract][Full Text] [Related]
10. Expression and transport function of drug uptake transporters in differentiated HepaRG cells.
Kotani N; Maeda K; Debori Y; Camus S; Li R; Chesne C; Sugiyama Y
Mol Pharm; 2012 Dec; 9(12):3434-41. PubMed ID: 22897388
[TBL] [Abstract][Full Text] [Related]
11. Differential disposition of chenodeoxycholic acid versus taurocholic acid in response to acute troglitazone exposure in rat hepatocytes.
Marion TL; Perry CH; St Claire RL; Yue W; Brouwer KL
Toxicol Sci; 2011 Apr; 120(2):371-80. PubMed ID: 21262925
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity.
Leslie EM; Watkins PB; Kim RB; Brouwer KL
J Pharmacol Exp Ther; 2007 Jun; 321(3):1170-8. PubMed ID: 17374746
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
[TBL] [Abstract][Full Text] [Related]
14. Ritonavir, saquinavir, and efavirenz, but not nevirapine, inhibit bile acid transport in human and rat hepatocytes.
McRae MP; Lowe CM; Tian X; Bourdet DL; Ho RH; Leake BF; Kim RB; Brouwer KL; Kashuba AD
J Pharmacol Exp Ther; 2006 Sep; 318(3):1068-75. PubMed ID: 16720753
[TBL] [Abstract][Full Text] [Related]
15. Bile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human Hepatocytes.
Woolbright BL; McGill MR; Yan H; Jaeschke H
Basic Clin Pharmacol Toxicol; 2016 Feb; 118(2):160-7. PubMed ID: 26176423
[TBL] [Abstract][Full Text] [Related]
16. Contribution of high basolateral bile salt efflux to the lack of hepatotoxicity in rat in response to drugs inducing cholestasis in human.
Jemnitz K; Veres Z; Vereczkey L
Toxicol Sci; 2010 May; 115(1):80-8. PubMed ID: 20147439
[TBL] [Abstract][Full Text] [Related]
17. Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transport.
Wolf KK; Vora S; Webster LO; Generaux GT; Polli JW; Brouwer KL
Toxicol In Vitro; 2010 Feb; 24(1):297-309. PubMed ID: 19706322
[TBL] [Abstract][Full Text] [Related]
18. Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells.
Le Vee M; Noel G; Jouan E; Stieger B; Fardel O
Toxicol In Vitro; 2013 Sep; 27(6):1979-86. PubMed ID: 23850984
[TBL] [Abstract][Full Text] [Related]
19. Endogenous bile acid disposition in rat and human sandwich-cultured hepatocytes.
Marion TL; Perry CH; St Claire RL; Brouwer KL
Toxicol Appl Pharmacol; 2012 May; 261(1):1-9. PubMed ID: 22342602
[TBL] [Abstract][Full Text] [Related]
20. Organic solute transporter OSTα/β is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury.
Malinen MM; Ali I; Bezençon J; Beaudoin JJ; Brouwer KLR
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G597-G609. PubMed ID: 29420067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
